STOCK TITAN

Ambase Financials

ABCP
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Ambase (ABCP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ABCP FY2025

Balance-sheet erosion is the dominant mechanic, with assets and cash nearly exhausted while liabilities keep accumulating.

From FY2021 to FY2025, total assets fell from $3.1M to $87K. Over the same span, total liabilities rose from $684K to $8.8M, so the company became a much smaller asset base supporting a much larger set of claims.

The move from positive equity of $2.4M in FY2021 to negative equity of -$8.7M in FY2025 means obligations now exceed the recorded asset base. Share count more than doubled by FY2024 to 84.9M shares, showing the capital structure changed materially without rebuilding a balance-sheet cushion.

Some figures from recent filings were inconsistent and were omitted from this summary.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating Ambase's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
N/A
EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$87K
YoY-72.3%
5Y CAGR-59.4%
10Y CAGR-30.5%

Ambase held $87K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
85M
YoY+0.0%
5Y CAGR+15.8%
10Y CAGR+7.6%

Ambase had 85M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

ABCP Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $324K N/A $324K+0.6% $322K-13.2% $371K N/A $345K-2.0% $352K
Operating Income -$678K N/A -$985K N/A N/A N/A -$1.5M+24.0% -$2.0M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax $0 N/A $0 $0 $0 N/A $0 $0
Net Income -$775K N/A -$1.1M N/A N/A N/A -$1.5M+20.8% -$1.9M
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

ABCP Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $533K+512.6% $87K-63.6% $239K+119.3% $109K-45.5% $200K-36.3% $314K-39.0% $515K+18.7% $434K
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $533K+512.6% $87K-63.6% $239K+119.3% $109K-45.5% $200K-36.3% $314K-39.0% $515K+18.7% $434K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $10.0M+13.9% $8.8M+7.9% $8.1M+17.7% $6.9M+16.8% $5.9M+33.3% $4.4M+33.4% $3.3M+94.2% $1.7M
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$9.5M-8.9% -$8.7M-10.1% -$7.9M-16.0% -$6.8M-18.9% -$5.7M-38.6% -$4.1M-46.7% -$2.8M-119.9% -$1.3M
Retained Earnings -$561.9M-0.1% -$561.1M-0.1% -$560.3M-0.2% -$559.2M-0.2% -$558.2M-0.3% -$556.6M-0.2% -$555.3M-0.3% -$553.7M

ABCP Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$1.5M N/A -$470K N/A -$614K+12.4% -$701K N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow $1.9M+375.0% $400K-33.3% $600K N/A $500K0.0% $500K N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

ABCP Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -145.4% N/A -456.5% N/A N/A N/A -297.7%+148.2pp -445.8%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity N/A N/A N/A N/A N/A N/A N/A N/A
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$8.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

Ambase (ABCP) had $87K in total assets as of fiscal year 2025, including both current and long-term assets.

Ambase (ABCP) had 85M shares outstanding as of fiscal year 2025.

Ambase (ABCP) has negative shareholder equity of -$8.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top